z-logo
open-access-imgOpen Access
Substrate reduction therapy as a new treatment option for patients with Gaucher disease type 1: A review of literatures
Author(s) -
Young Bae Sohn,
HanWook Yoo
Publication year - 2016
Publication title -
journal of genetic medicine
Language(s) - English
Resource type - Journals
eISSN - 2233-9108
pISSN - 1226-1769
DOI - 10.5734/jgm.2016.13.2.59
Subject(s) - substrate reduction therapy , enzyme replacement therapy , reduction (mathematics) , medicine , dosing , substrate (aquarium) , disease , biology , ecology , geometry , mathematics
Gaucher disease type 1 (GD1) is an inherited lysosomal storage disorder caused by deficiency of acid β-glucosidase. The diminished enzyme activity...

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom